| 1 |
18199798 | ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. | 2008 Apr |
1 |
| 2 |
16572114 | Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. | 2006 May |
1 |
| 3 |
17009077 | Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study. | 2006 Sep |
1 |
| 4 |
19804143 | Losartan in cardiovascular disease. | 2005 Jul |
1 |
| 5 |
24678070 | Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus: A retrospective cost-effectiveness analysis in the United Kingdom. | 2005 Nov |
1 |
| 6 |
15047641 | Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. | 2004 Apr |
1 |
| 7 |
15152291 | Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective. | 2004 May 1 |
1 |
| 8 |
15225108 | Losartan in diabetic nephropathy. | 2004 Jul |
1 |
| 9 |
15369420 | Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control. | 2004 Sep |
1 |
| 10 |
15485403 | Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy. | 2004 Nov |
1 |
| 11 |
15500378 | Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. | 2004 Nov |
1 |
| 12 |
12610022 | Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. | 2003 Mar |
1 |
| 13 |
12121010 | Recent landmark clinical trials: how do they modify the therapeutic paradigm? | 2002 Jul |
1 |
| 14 |
12182249 | The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies. | 2002 Jul |
1 |
| 15 |
12410858 | Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study. | 2002 Dec |
1 |